Cargando…
ITGB4 as a novel serum diagnosis biomarker and potential therapeutic target for colorectal cancer
PURPOSE: To develop new and effective biomarkers for the diagnosis of colorectal cancer (CRC). EXPERIMENTAL DESIGN: The serum expression of ITGB4 (49 CRC and 367 HC) was detected by enzyme‐linked immunosorbent assay (ELISA), and its diagnostic value was analyzed using the receiver operating characte...
Autores principales: | Jiang, Xia, Wang, Jia, Wang, Mengyu, Xuan, Mingda, Han, Shuangshuang, Li, Chao, Li, Meng, Sun, Xiao‐Feng, Yu, Weifang, Zhao, Zengren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495272/ https://www.ncbi.nlm.nih.gov/pubmed/34414684 http://dx.doi.org/10.1002/cam4.4216 |
Ejemplares similares
-
miR-17-5p promotes the invasion and migration of colorectal cancer by regulating HSPB2
por: Yu, Weifang, et al.
Publicado: (2022) -
ITGB4 is a novel prognostic factor in colon cancer
por: Li, Meng, et al.
Publicado: (2019) -
Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor
por: Chu, Ling-Yu, et al.
Publicado: (2021) -
Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer
por: Liu, Dongliang, et al.
Publicado: (2022) -
Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy
por: Gao, Qianqian, et al.
Publicado: (2019)